Global Tumor NGS Detection Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The main purpose of NGS is to discover clinically treatable genetic variants and guide patient treatment.
The global Tumor NGS Detection market size is projected to grow from US$ 1795.1 million in 2023 to US$ 5194.1 million in 2030; it is expected to grow at a CAGR of 16.4% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Tumor NGS Detection Industry Forecast” looks at past sales and reviews total world Tumor NGS Detection sales in 2023, providing a comprehensive analysis by region and market sector of projected Tumor NGS Detection sales for 2024 through 2030. With Tumor NGS Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor NGS Detection industry.
This Insight Report provides a comprehensive analysis of the global Tumor NGS Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor NGS Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor NGS Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor NGS Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor NGS Detection.
United States market for Tumor NGS Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Tumor NGS Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Tumor NGS Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Tumor NGS Detection players cover Agilent, Thermo Fisher Scientific, BGI Group, Roche Foundation Medicine and Sinopharm Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor NGS Detection market by product type, application, key players and key regions and countries.
Segmentation by type
The main purpose of NGS is to discover clinically treatable genetic variants and guide patient treatment.
The global Tumor NGS Detection market size is projected to grow from US$ 1795.1 million in 2023 to US$ 5194.1 million in 2030; it is expected to grow at a CAGR of 16.4% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Tumor NGS Detection Industry Forecast” looks at past sales and reviews total world Tumor NGS Detection sales in 2023, providing a comprehensive analysis by region and market sector of projected Tumor NGS Detection sales for 2024 through 2030. With Tumor NGS Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor NGS Detection industry.
This Insight Report provides a comprehensive analysis of the global Tumor NGS Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor NGS Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor NGS Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor NGS Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor NGS Detection.
United States market for Tumor NGS Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Tumor NGS Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Tumor NGS Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Tumor NGS Detection players cover Agilent, Thermo Fisher Scientific, BGI Group, Roche Foundation Medicine and Sinopharm Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor NGS Detection market by product type, application, key players and key regions and countries.
Segmentation by type
- Medical Equipment
- Consumables
- Companion Diagnostics
- Early Cancer Screening
- Drug Discovery
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Agilent
- Thermo Fisher Scientific
- BGI Group
- Roche Foundation Medicine
- Sinopharm Group
- Fosunpharma
- Novogene
- Geneseeq
- AmoyDx
- Burning Rock Medicine
- Perkin Elmer
- Qiagen NV
- Partek
- Illumina Inc.
- Pacific Biosciences of California Inc.
- Life Technologies Corporation
- GTH.O
- Paradigm Diagnostics
- Oxford Nanopore Technologies Ltd.
- Eurofins Scientific S.E.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor NGS Detection Market Size 2019-2030
2.1.2 Tumor NGS Detection Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Tumor NGS Detection Segment by Type
2.2.1 Medical Equipment
2.2.2 Consumables
2.3 Tumor NGS Detection Market Size by Type
2.3.1 Tumor NGS Detection Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Tumor NGS Detection Market Size Market Share by Type (2019-2024)
2.4 Tumor NGS Detection Segment by Application
2.4.1 Companion Diagnostics
2.4.2 Early Cancer Screening
2.4.3 Drug Discovery
2.4.4 Other
2.5 Tumor NGS Detection Market Size by Application
2.5.1 Tumor NGS Detection Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Tumor NGS Detection Market Size Market Share by Application (2019-2024)
3 TUMOR NGS DETECTION MARKET SIZE BY PLAYER
3.1 Tumor NGS Detection Market Size Market Share by Players
3.1.1 Global Tumor NGS Detection Revenue by Players (2019-2024)
3.1.2 Global Tumor NGS Detection Revenue Market Share by Players (2019-2024)
3.2 Global Tumor NGS Detection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUMOR NGS DETECTION BY REGIONS
4.1 Tumor NGS Detection Market Size by Regions (2019-2024)
4.2 Americas Tumor NGS Detection Market Size Growth (2019-2024)
4.3 APAC Tumor NGS Detection Market Size Growth (2019-2024)
4.4 Europe Tumor NGS Detection Market Size Growth (2019-2024)
4.5 Middle East & Africa Tumor NGS Detection Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Tumor NGS Detection Market Size by Country (2019-2024)
5.2 Americas Tumor NGS Detection Market Size by Type (2019-2024)
5.3 Americas Tumor NGS Detection Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor NGS Detection Market Size by Region (2019-2024)
6.2 APAC Tumor NGS Detection Market Size by Type (2019-2024)
6.3 APAC Tumor NGS Detection Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tumor NGS Detection by Country (2019-2024)
7.2 Europe Tumor NGS Detection Market Size by Type (2019-2024)
7.3 Europe Tumor NGS Detection Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor NGS Detection by Region (2019-2024)
8.2 Middle East & Africa Tumor NGS Detection Market Size by Type (2019-2024)
8.3 Middle East & Africa Tumor NGS Detection Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUMOR NGS DETECTION MARKET FORECAST
10.1 Global Tumor NGS Detection Forecast by Regions (2025-2030)
10.1.1 Global Tumor NGS Detection Forecast by Regions (2025-2030)
10.1.2 Americas Tumor NGS Detection Forecast
10.1.3 APAC Tumor NGS Detection Forecast
10.1.4 Europe Tumor NGS Detection Forecast
10.1.5 Middle East & Africa Tumor NGS Detection Forecast
10.2 Americas Tumor NGS Detection Forecast by Country (2025-2030)
10.2.1 United States Tumor NGS Detection Market Forecast
10.2.2 Canada Tumor NGS Detection Market Forecast
10.2.3 Mexico Tumor NGS Detection Market Forecast
10.2.4 Brazil Tumor NGS Detection Market Forecast
10.3 APAC Tumor NGS Detection Forecast by Region (2025-2030)
10.3.1 China Tumor NGS Detection Market Forecast
10.3.2 Japan Tumor NGS Detection Market Forecast
10.3.3 Korea Tumor NGS Detection Market Forecast
10.3.4 Southeast Asia Tumor NGS Detection Market Forecast
10.3.5 India Tumor NGS Detection Market Forecast
10.3.6 Australia Tumor NGS Detection Market Forecast
10.4 Europe Tumor NGS Detection Forecast by Country (2025-2030)
10.4.1 Germany Tumor NGS Detection Market Forecast
10.4.2 France Tumor NGS Detection Market Forecast
10.4.3 UK Tumor NGS Detection Market Forecast
10.4.4 Italy Tumor NGS Detection Market Forecast
10.4.5 Russia Tumor NGS Detection Market Forecast
10.5 Middle East & Africa Tumor NGS Detection Forecast by Region (2025-2030)
10.5.1 Egypt Tumor NGS Detection Market Forecast
10.5.2 South Africa Tumor NGS Detection Market Forecast
10.5.3 Israel Tumor NGS Detection Market Forecast
10.5.4 Turkey Tumor NGS Detection Market Forecast
10.5.5 GCC Countries Tumor NGS Detection Market Forecast
10.6 Global Tumor NGS Detection Forecast by Type (2025-2030)
10.7 Global Tumor NGS Detection Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Agilent
11.1.1 Agilent Company Information
11.1.2 Agilent Tumor NGS Detection Product Offered
11.1.3 Agilent Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Agilent Main Business Overview
11.1.5 Agilent Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Tumor NGS Detection Product Offered
11.2.3 Thermo Fisher Scientific Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 BGI Group
11.3.1 BGI Group Company Information
11.3.2 BGI Group Tumor NGS Detection Product Offered
11.3.3 BGI Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 BGI Group Main Business Overview
11.3.5 BGI Group Latest Developments
11.4 Roche Foundation Medicine
11.4.1 Roche Foundation Medicine Company Information
11.4.2 Roche Foundation Medicine Tumor NGS Detection Product Offered
11.4.3 Roche Foundation Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Roche Foundation Medicine Main Business Overview
11.4.5 Roche Foundation Medicine Latest Developments
11.5 Sinopharm Group
11.5.1 Sinopharm Group Company Information
11.5.2 Sinopharm Group Tumor NGS Detection Product Offered
11.5.3 Sinopharm Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sinopharm Group Main Business Overview
11.5.5 Sinopharm Group Latest Developments
11.6 Fosunpharma
11.6.1 Fosunpharma Company Information
11.6.2 Fosunpharma Tumor NGS Detection Product Offered
11.6.3 Fosunpharma Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Fosunpharma Main Business Overview
11.6.5 Fosunpharma Latest Developments
11.7 Novogene
11.7.1 Novogene Company Information
11.7.2 Novogene Tumor NGS Detection Product Offered
11.7.3 Novogene Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novogene Main Business Overview
11.7.5 Novogene Latest Developments
11.8 Geneseeq
11.8.1 Geneseeq Company Information
11.8.2 Geneseeq Tumor NGS Detection Product Offered
11.8.3 Geneseeq Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Geneseeq Main Business Overview
11.8.5 Geneseeq Latest Developments
11.9 AmoyDx
11.9.1 AmoyDx Company Information
11.9.2 AmoyDx Tumor NGS Detection Product Offered
11.9.3 AmoyDx Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 AmoyDx Main Business Overview
11.9.5 AmoyDx Latest Developments
11.10 Burning Rock Medicine
11.10.1 Burning Rock Medicine Company Information
11.10.2 Burning Rock Medicine Tumor NGS Detection Product Offered
11.10.3 Burning Rock Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Burning Rock Medicine Main Business Overview
11.10.5 Burning Rock Medicine Latest Developments
11.11 Perkin Elmer
11.11.1 Perkin Elmer Company Information
11.11.2 Perkin Elmer Tumor NGS Detection Product Offered
11.11.3 Perkin Elmer Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Perkin Elmer Main Business Overview
11.11.5 Perkin Elmer Latest Developments
11.12 Qiagen NV
11.12.1 Qiagen NV Company Information
11.12.2 Qiagen NV Tumor NGS Detection Product Offered
11.12.3 Qiagen NV Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Qiagen NV Main Business Overview
11.12.5 Qiagen NV Latest Developments
11.13 Partek
11.13.1 Partek Company Information
11.13.2 Partek Tumor NGS Detection Product Offered
11.13.3 Partek Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Partek Main Business Overview
11.13.5 Partek Latest Developments
11.14 Illumina Inc.
11.14.1 Illumina Inc. Company Information
11.14.2 Illumina Inc. Tumor NGS Detection Product Offered
11.14.3 Illumina Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Illumina Inc. Main Business Overview
11.14.5 Illumina Inc. Latest Developments
11.15 Pacific Biosciences of California Inc.
11.15.1 Pacific Biosciences of California Inc. Company Information
11.15.2 Pacific Biosciences of California Inc. Tumor NGS Detection Product Offered
11.15.3 Pacific Biosciences of California Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Pacific Biosciences of California Inc. Main Business Overview
11.15.5 Pacific Biosciences of California Inc. Latest Developments
11.16 Life Technologies Corporation
11.16.1 Life Technologies Corporation Company Information
11.16.2 Life Technologies Corporation Tumor NGS Detection Product Offered
11.16.3 Life Technologies Corporation Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Life Technologies Corporation Main Business Overview
11.16.5 Life Technologies Corporation Latest Developments
11.17 GTH.O
11.17.1 GTH.O Company Information
11.17.2 GTH.O Tumor NGS Detection Product Offered
11.17.3 GTH.O Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 GTH.O Main Business Overview
11.17.5 GTH.O Latest Developments
11.18 Paradigm Diagnostics
11.18.1 Paradigm Diagnostics Company Information
11.18.2 Paradigm Diagnostics Tumor NGS Detection Product Offered
11.18.3 Paradigm Diagnostics Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Paradigm Diagnostics Main Business Overview
11.18.5 Paradigm Diagnostics Latest Developments
11.19 Oxford Nanopore Technologies Ltd.
11.19.1 Oxford Nanopore Technologies Ltd. Company Information
11.19.2 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product Offered
11.19.3 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Oxford Nanopore Technologies Ltd. Main Business Overview
11.19.5 Oxford Nanopore Technologies Ltd. Latest Developments
11.20 Eurofins Scientific S.E.
11.20.1 Eurofins Scientific S.E. Company Information
11.20.2 Eurofins Scientific S.E. Tumor NGS Detection Product Offered
11.20.3 Eurofins Scientific S.E. Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Eurofins Scientific S.E. Main Business Overview
11.20.5 Eurofins Scientific S.E. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor NGS Detection Market Size 2019-2030
2.1.2 Tumor NGS Detection Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Tumor NGS Detection Segment by Type
2.2.1 Medical Equipment
2.2.2 Consumables
2.3 Tumor NGS Detection Market Size by Type
2.3.1 Tumor NGS Detection Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Tumor NGS Detection Market Size Market Share by Type (2019-2024)
2.4 Tumor NGS Detection Segment by Application
2.4.1 Companion Diagnostics
2.4.2 Early Cancer Screening
2.4.3 Drug Discovery
2.4.4 Other
2.5 Tumor NGS Detection Market Size by Application
2.5.1 Tumor NGS Detection Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Tumor NGS Detection Market Size Market Share by Application (2019-2024)
3 TUMOR NGS DETECTION MARKET SIZE BY PLAYER
3.1 Tumor NGS Detection Market Size Market Share by Players
3.1.1 Global Tumor NGS Detection Revenue by Players (2019-2024)
3.1.2 Global Tumor NGS Detection Revenue Market Share by Players (2019-2024)
3.2 Global Tumor NGS Detection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUMOR NGS DETECTION BY REGIONS
4.1 Tumor NGS Detection Market Size by Regions (2019-2024)
4.2 Americas Tumor NGS Detection Market Size Growth (2019-2024)
4.3 APAC Tumor NGS Detection Market Size Growth (2019-2024)
4.4 Europe Tumor NGS Detection Market Size Growth (2019-2024)
4.5 Middle East & Africa Tumor NGS Detection Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Tumor NGS Detection Market Size by Country (2019-2024)
5.2 Americas Tumor NGS Detection Market Size by Type (2019-2024)
5.3 Americas Tumor NGS Detection Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor NGS Detection Market Size by Region (2019-2024)
6.2 APAC Tumor NGS Detection Market Size by Type (2019-2024)
6.3 APAC Tumor NGS Detection Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tumor NGS Detection by Country (2019-2024)
7.2 Europe Tumor NGS Detection Market Size by Type (2019-2024)
7.3 Europe Tumor NGS Detection Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor NGS Detection by Region (2019-2024)
8.2 Middle East & Africa Tumor NGS Detection Market Size by Type (2019-2024)
8.3 Middle East & Africa Tumor NGS Detection Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUMOR NGS DETECTION MARKET FORECAST
10.1 Global Tumor NGS Detection Forecast by Regions (2025-2030)
10.1.1 Global Tumor NGS Detection Forecast by Regions (2025-2030)
10.1.2 Americas Tumor NGS Detection Forecast
10.1.3 APAC Tumor NGS Detection Forecast
10.1.4 Europe Tumor NGS Detection Forecast
10.1.5 Middle East & Africa Tumor NGS Detection Forecast
10.2 Americas Tumor NGS Detection Forecast by Country (2025-2030)
10.2.1 United States Tumor NGS Detection Market Forecast
10.2.2 Canada Tumor NGS Detection Market Forecast
10.2.3 Mexico Tumor NGS Detection Market Forecast
10.2.4 Brazil Tumor NGS Detection Market Forecast
10.3 APAC Tumor NGS Detection Forecast by Region (2025-2030)
10.3.1 China Tumor NGS Detection Market Forecast
10.3.2 Japan Tumor NGS Detection Market Forecast
10.3.3 Korea Tumor NGS Detection Market Forecast
10.3.4 Southeast Asia Tumor NGS Detection Market Forecast
10.3.5 India Tumor NGS Detection Market Forecast
10.3.6 Australia Tumor NGS Detection Market Forecast
10.4 Europe Tumor NGS Detection Forecast by Country (2025-2030)
10.4.1 Germany Tumor NGS Detection Market Forecast
10.4.2 France Tumor NGS Detection Market Forecast
10.4.3 UK Tumor NGS Detection Market Forecast
10.4.4 Italy Tumor NGS Detection Market Forecast
10.4.5 Russia Tumor NGS Detection Market Forecast
10.5 Middle East & Africa Tumor NGS Detection Forecast by Region (2025-2030)
10.5.1 Egypt Tumor NGS Detection Market Forecast
10.5.2 South Africa Tumor NGS Detection Market Forecast
10.5.3 Israel Tumor NGS Detection Market Forecast
10.5.4 Turkey Tumor NGS Detection Market Forecast
10.5.5 GCC Countries Tumor NGS Detection Market Forecast
10.6 Global Tumor NGS Detection Forecast by Type (2025-2030)
10.7 Global Tumor NGS Detection Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Agilent
11.1.1 Agilent Company Information
11.1.2 Agilent Tumor NGS Detection Product Offered
11.1.3 Agilent Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Agilent Main Business Overview
11.1.5 Agilent Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Tumor NGS Detection Product Offered
11.2.3 Thermo Fisher Scientific Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 BGI Group
11.3.1 BGI Group Company Information
11.3.2 BGI Group Tumor NGS Detection Product Offered
11.3.3 BGI Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 BGI Group Main Business Overview
11.3.5 BGI Group Latest Developments
11.4 Roche Foundation Medicine
11.4.1 Roche Foundation Medicine Company Information
11.4.2 Roche Foundation Medicine Tumor NGS Detection Product Offered
11.4.3 Roche Foundation Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Roche Foundation Medicine Main Business Overview
11.4.5 Roche Foundation Medicine Latest Developments
11.5 Sinopharm Group
11.5.1 Sinopharm Group Company Information
11.5.2 Sinopharm Group Tumor NGS Detection Product Offered
11.5.3 Sinopharm Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sinopharm Group Main Business Overview
11.5.5 Sinopharm Group Latest Developments
11.6 Fosunpharma
11.6.1 Fosunpharma Company Information
11.6.2 Fosunpharma Tumor NGS Detection Product Offered
11.6.3 Fosunpharma Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Fosunpharma Main Business Overview
11.6.5 Fosunpharma Latest Developments
11.7 Novogene
11.7.1 Novogene Company Information
11.7.2 Novogene Tumor NGS Detection Product Offered
11.7.3 Novogene Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novogene Main Business Overview
11.7.5 Novogene Latest Developments
11.8 Geneseeq
11.8.1 Geneseeq Company Information
11.8.2 Geneseeq Tumor NGS Detection Product Offered
11.8.3 Geneseeq Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Geneseeq Main Business Overview
11.8.5 Geneseeq Latest Developments
11.9 AmoyDx
11.9.1 AmoyDx Company Information
11.9.2 AmoyDx Tumor NGS Detection Product Offered
11.9.3 AmoyDx Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 AmoyDx Main Business Overview
11.9.5 AmoyDx Latest Developments
11.10 Burning Rock Medicine
11.10.1 Burning Rock Medicine Company Information
11.10.2 Burning Rock Medicine Tumor NGS Detection Product Offered
11.10.3 Burning Rock Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Burning Rock Medicine Main Business Overview
11.10.5 Burning Rock Medicine Latest Developments
11.11 Perkin Elmer
11.11.1 Perkin Elmer Company Information
11.11.2 Perkin Elmer Tumor NGS Detection Product Offered
11.11.3 Perkin Elmer Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Perkin Elmer Main Business Overview
11.11.5 Perkin Elmer Latest Developments
11.12 Qiagen NV
11.12.1 Qiagen NV Company Information
11.12.2 Qiagen NV Tumor NGS Detection Product Offered
11.12.3 Qiagen NV Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Qiagen NV Main Business Overview
11.12.5 Qiagen NV Latest Developments
11.13 Partek
11.13.1 Partek Company Information
11.13.2 Partek Tumor NGS Detection Product Offered
11.13.3 Partek Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Partek Main Business Overview
11.13.5 Partek Latest Developments
11.14 Illumina Inc.
11.14.1 Illumina Inc. Company Information
11.14.2 Illumina Inc. Tumor NGS Detection Product Offered
11.14.3 Illumina Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Illumina Inc. Main Business Overview
11.14.5 Illumina Inc. Latest Developments
11.15 Pacific Biosciences of California Inc.
11.15.1 Pacific Biosciences of California Inc. Company Information
11.15.2 Pacific Biosciences of California Inc. Tumor NGS Detection Product Offered
11.15.3 Pacific Biosciences of California Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Pacific Biosciences of California Inc. Main Business Overview
11.15.5 Pacific Biosciences of California Inc. Latest Developments
11.16 Life Technologies Corporation
11.16.1 Life Technologies Corporation Company Information
11.16.2 Life Technologies Corporation Tumor NGS Detection Product Offered
11.16.3 Life Technologies Corporation Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Life Technologies Corporation Main Business Overview
11.16.5 Life Technologies Corporation Latest Developments
11.17 GTH.O
11.17.1 GTH.O Company Information
11.17.2 GTH.O Tumor NGS Detection Product Offered
11.17.3 GTH.O Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 GTH.O Main Business Overview
11.17.5 GTH.O Latest Developments
11.18 Paradigm Diagnostics
11.18.1 Paradigm Diagnostics Company Information
11.18.2 Paradigm Diagnostics Tumor NGS Detection Product Offered
11.18.3 Paradigm Diagnostics Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Paradigm Diagnostics Main Business Overview
11.18.5 Paradigm Diagnostics Latest Developments
11.19 Oxford Nanopore Technologies Ltd.
11.19.1 Oxford Nanopore Technologies Ltd. Company Information
11.19.2 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product Offered
11.19.3 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Oxford Nanopore Technologies Ltd. Main Business Overview
11.19.5 Oxford Nanopore Technologies Ltd. Latest Developments
11.20 Eurofins Scientific S.E.
11.20.1 Eurofins Scientific S.E. Company Information
11.20.2 Eurofins Scientific S.E. Tumor NGS Detection Product Offered
11.20.3 Eurofins Scientific S.E. Tumor NGS Detection Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Eurofins Scientific S.E. Main Business Overview
11.20.5 Eurofins Scientific S.E. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tumor NGS Detection Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Medical Equipment
Table 3. Major Players of Consumables
Table 4. Tumor NGS Detection Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Tumor NGS Detection Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Tumor NGS Detection Market Size Market Share by Type (2019-2024)
Table 7. Tumor NGS Detection Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Tumor NGS Detection Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Tumor NGS Detection Market Size Market Share by Application (2019-2024)
Table 10. Global Tumor NGS Detection Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Tumor NGS Detection Revenue Market Share by Player (2019-2024)
Table 12. Tumor NGS Detection Key Players Head office and Products Offered
Table 13. Tumor NGS Detection Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Tumor NGS Detection Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Tumor NGS Detection Market Size Market Share by Regions (2019-2024)
Table 18. Global Tumor NGS Detection Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Tumor NGS Detection Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Tumor NGS Detection Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Tumor NGS Detection Market Size Market Share by Country (2019-2024)
Table 22. Americas Tumor NGS Detection Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Tumor NGS Detection Market Size Market Share by Type (2019-2024)
Table 24. Americas Tumor NGS Detection Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Tumor NGS Detection Market Size Market Share by Application (2019-2024)
Table 26. APAC Tumor NGS Detection Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Tumor NGS Detection Market Size Market Share by Region (2019-2024)
Table 28. APAC Tumor NGS Detection Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Tumor NGS Detection Market Size Market Share by Type (2019-2024)
Table 30. APAC Tumor NGS Detection Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Tumor NGS Detection Market Size Market Share by Application (2019-2024)
Table 32. Europe Tumor NGS Detection Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Tumor NGS Detection Market Size Market Share by Country (2019-2024)
Table 34. Europe Tumor NGS Detection Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Tumor NGS Detection Market Size Market Share by Type (2019-2024)
Table 36. Europe Tumor NGS Detection Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Tumor NGS Detection Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Tumor NGS Detection Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Tumor NGS Detection Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Tumor NGS Detection Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Tumor NGS Detection Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Tumor NGS Detection Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Tumor NGS Detection Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Tumor NGS Detection
Table 45. Key Market Challenges & Risks of Tumor NGS Detection
Table 46. Key Industry Trends of Tumor NGS Detection
Table 47. Global Tumor NGS Detection Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Tumor NGS Detection Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Tumor NGS Detection Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Tumor NGS Detection Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Agilent Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 52. Agilent Tumor NGS Detection Product Offered
Table 53. Agilent Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Agilent Main Business
Table 55. Agilent Latest Developments
Table 56. Thermo Fisher Scientific Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 57. Thermo Fisher Scientific Tumor NGS Detection Product Offered
Table 58. Thermo Fisher Scientific Main Business
Table 59. Thermo Fisher Scientific Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Thermo Fisher Scientific Latest Developments
Table 61. BGI Group Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 62. BGI Group Tumor NGS Detection Product Offered
Table 63. BGI Group Main Business
Table 64. BGI Group Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. BGI Group Latest Developments
Table 66. Roche Foundation Medicine Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 67. Roche Foundation Medicine Tumor NGS Detection Product Offered
Table 68. Roche Foundation Medicine Main Business
Table 69. Roche Foundation Medicine Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Roche Foundation Medicine Latest Developments
Table 71. Sinopharm Group Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 72. Sinopharm Group Tumor NGS Detection Product Offered
Table 73. Sinopharm Group Main Business
Table 74. Sinopharm Group Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Sinopharm Group Latest Developments
Table 76. Fosunpharma Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 77. Fosunpharma Tumor NGS Detection Product Offered
Table 78. Fosunpharma Main Business
Table 79. Fosunpharma Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Fosunpharma Latest Developments
Table 81. Novogene Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 82. Novogene Tumor NGS Detection Product Offered
Table 83. Novogene Main Business
Table 84. Novogene Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Novogene Latest Developments
Table 86. Geneseeq Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 87. Geneseeq Tumor NGS Detection Product Offered
Table 88. Geneseeq Main Business
Table 89. Geneseeq Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Geneseeq Latest Developments
Table 91. AmoyDx Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 92. AmoyDx Tumor NGS Detection Product Offered
Table 93. AmoyDx Main Business
Table 94. AmoyDx Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. AmoyDx Latest Developments
Table 96. Burning Rock Medicine Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 97. Burning Rock Medicine Tumor NGS Detection Product Offered
Table 98. Burning Rock Medicine Main Business
Table 99. Burning Rock Medicine Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Burning Rock Medicine Latest Developments
Table 101. Perkin Elmer Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 102. Perkin Elmer Tumor NGS Detection Product Offered
Table 103. Perkin Elmer Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Perkin Elmer Main Business
Table 105. Perkin Elmer Latest Developments
Table 106. Qiagen NV Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 107. Qiagen NV Tumor NGS Detection Product Offered
Table 108. Qiagen NV Main Business
Table 109. Qiagen NV Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Qiagen NV Latest Developments
Table 111. Partek Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 112. Partek Tumor NGS Detection Product Offered
Table 113. Partek Main Business
Table 114. Partek Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Partek Latest Developments
Table 116. Illumina Inc. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 117. Illumina Inc. Tumor NGS Detection Product Offered
Table 118. Illumina Inc. Main Business
Table 119. Illumina Inc. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Illumina Inc. Latest Developments
Table 121. Pacific Biosciences of California Inc. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 122. Pacific Biosciences of California Inc. Tumor NGS Detection Product Offered
Table 123. Pacific Biosciences of California Inc. Main Business
Table 124. Pacific Biosciences of California Inc. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Pacific Biosciences of California Inc. Latest Developments
Table 126. Life Technologies Corporation Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 127. Life Technologies Corporation Tumor NGS Detection Product Offered
Table 128. Life Technologies Corporation Main Business
Table 129. Life Technologies Corporation Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 130. Life Technologies Corporation Latest Developments
Table 131. GTH.O Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 132. GTH.O Tumor NGS Detection Product Offered
Table 133. GTH.O Main Business
Table 134. GTH.O Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 135. GTH.O Latest Developments
Table 136. Paradigm Diagnostics Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 137. Paradigm Diagnostics Tumor NGS Detection Product Offered
Table 138. Paradigm Diagnostics Main Business
Table 139. Paradigm Diagnostics Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 140. Paradigm Diagnostics Latest Developments
Table 141. Oxford Nanopore Technologies Ltd. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 142. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product Offered
Table 143. Oxford Nanopore Technologies Ltd. Main Business
Table 144. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 145. Oxford Nanopore Technologies Ltd. Latest Developments
Table 146. Eurofins Scientific S.E. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 147. Eurofins Scientific S.E. Tumor NGS Detection Product Offered
Table 148. Eurofins Scientific S.E. Main Business
Table 149. Eurofins Scientific S.E. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 150. Eurofins Scientific S.E. Latest Developments
Table 1. Tumor NGS Detection Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Medical Equipment
Table 3. Major Players of Consumables
Table 4. Tumor NGS Detection Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Tumor NGS Detection Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Tumor NGS Detection Market Size Market Share by Type (2019-2024)
Table 7. Tumor NGS Detection Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Tumor NGS Detection Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Tumor NGS Detection Market Size Market Share by Application (2019-2024)
Table 10. Global Tumor NGS Detection Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Tumor NGS Detection Revenue Market Share by Player (2019-2024)
Table 12. Tumor NGS Detection Key Players Head office and Products Offered
Table 13. Tumor NGS Detection Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Tumor NGS Detection Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Tumor NGS Detection Market Size Market Share by Regions (2019-2024)
Table 18. Global Tumor NGS Detection Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Tumor NGS Detection Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Tumor NGS Detection Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Tumor NGS Detection Market Size Market Share by Country (2019-2024)
Table 22. Americas Tumor NGS Detection Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Tumor NGS Detection Market Size Market Share by Type (2019-2024)
Table 24. Americas Tumor NGS Detection Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Tumor NGS Detection Market Size Market Share by Application (2019-2024)
Table 26. APAC Tumor NGS Detection Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Tumor NGS Detection Market Size Market Share by Region (2019-2024)
Table 28. APAC Tumor NGS Detection Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Tumor NGS Detection Market Size Market Share by Type (2019-2024)
Table 30. APAC Tumor NGS Detection Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Tumor NGS Detection Market Size Market Share by Application (2019-2024)
Table 32. Europe Tumor NGS Detection Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Tumor NGS Detection Market Size Market Share by Country (2019-2024)
Table 34. Europe Tumor NGS Detection Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Tumor NGS Detection Market Size Market Share by Type (2019-2024)
Table 36. Europe Tumor NGS Detection Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Tumor NGS Detection Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Tumor NGS Detection Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Tumor NGS Detection Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Tumor NGS Detection Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Tumor NGS Detection Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Tumor NGS Detection Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Tumor NGS Detection Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Tumor NGS Detection
Table 45. Key Market Challenges & Risks of Tumor NGS Detection
Table 46. Key Industry Trends of Tumor NGS Detection
Table 47. Global Tumor NGS Detection Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Tumor NGS Detection Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Tumor NGS Detection Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Tumor NGS Detection Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Agilent Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 52. Agilent Tumor NGS Detection Product Offered
Table 53. Agilent Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Agilent Main Business
Table 55. Agilent Latest Developments
Table 56. Thermo Fisher Scientific Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 57. Thermo Fisher Scientific Tumor NGS Detection Product Offered
Table 58. Thermo Fisher Scientific Main Business
Table 59. Thermo Fisher Scientific Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Thermo Fisher Scientific Latest Developments
Table 61. BGI Group Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 62. BGI Group Tumor NGS Detection Product Offered
Table 63. BGI Group Main Business
Table 64. BGI Group Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. BGI Group Latest Developments
Table 66. Roche Foundation Medicine Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 67. Roche Foundation Medicine Tumor NGS Detection Product Offered
Table 68. Roche Foundation Medicine Main Business
Table 69. Roche Foundation Medicine Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Roche Foundation Medicine Latest Developments
Table 71. Sinopharm Group Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 72. Sinopharm Group Tumor NGS Detection Product Offered
Table 73. Sinopharm Group Main Business
Table 74. Sinopharm Group Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Sinopharm Group Latest Developments
Table 76. Fosunpharma Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 77. Fosunpharma Tumor NGS Detection Product Offered
Table 78. Fosunpharma Main Business
Table 79. Fosunpharma Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Fosunpharma Latest Developments
Table 81. Novogene Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 82. Novogene Tumor NGS Detection Product Offered
Table 83. Novogene Main Business
Table 84. Novogene Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Novogene Latest Developments
Table 86. Geneseeq Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 87. Geneseeq Tumor NGS Detection Product Offered
Table 88. Geneseeq Main Business
Table 89. Geneseeq Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Geneseeq Latest Developments
Table 91. AmoyDx Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 92. AmoyDx Tumor NGS Detection Product Offered
Table 93. AmoyDx Main Business
Table 94. AmoyDx Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. AmoyDx Latest Developments
Table 96. Burning Rock Medicine Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 97. Burning Rock Medicine Tumor NGS Detection Product Offered
Table 98. Burning Rock Medicine Main Business
Table 99. Burning Rock Medicine Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Burning Rock Medicine Latest Developments
Table 101. Perkin Elmer Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 102. Perkin Elmer Tumor NGS Detection Product Offered
Table 103. Perkin Elmer Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Perkin Elmer Main Business
Table 105. Perkin Elmer Latest Developments
Table 106. Qiagen NV Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 107. Qiagen NV Tumor NGS Detection Product Offered
Table 108. Qiagen NV Main Business
Table 109. Qiagen NV Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Qiagen NV Latest Developments
Table 111. Partek Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 112. Partek Tumor NGS Detection Product Offered
Table 113. Partek Main Business
Table 114. Partek Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Partek Latest Developments
Table 116. Illumina Inc. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 117. Illumina Inc. Tumor NGS Detection Product Offered
Table 118. Illumina Inc. Main Business
Table 119. Illumina Inc. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Illumina Inc. Latest Developments
Table 121. Pacific Biosciences of California Inc. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 122. Pacific Biosciences of California Inc. Tumor NGS Detection Product Offered
Table 123. Pacific Biosciences of California Inc. Main Business
Table 124. Pacific Biosciences of California Inc. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Pacific Biosciences of California Inc. Latest Developments
Table 126. Life Technologies Corporation Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 127. Life Technologies Corporation Tumor NGS Detection Product Offered
Table 128. Life Technologies Corporation Main Business
Table 129. Life Technologies Corporation Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 130. Life Technologies Corporation Latest Developments
Table 131. GTH.O Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 132. GTH.O Tumor NGS Detection Product Offered
Table 133. GTH.O Main Business
Table 134. GTH.O Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 135. GTH.O Latest Developments
Table 136. Paradigm Diagnostics Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 137. Paradigm Diagnostics Tumor NGS Detection Product Offered
Table 138. Paradigm Diagnostics Main Business
Table 139. Paradigm Diagnostics Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 140. Paradigm Diagnostics Latest Developments
Table 141. Oxford Nanopore Technologies Ltd. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 142. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product Offered
Table 143. Oxford Nanopore Technologies Ltd. Main Business
Table 144. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 145. Oxford Nanopore Technologies Ltd. Latest Developments
Table 146. Eurofins Scientific S.E. Details, Company Type, Tumor NGS Detection Area Served and Its Competitors
Table 147. Eurofins Scientific S.E. Tumor NGS Detection Product Offered
Table 148. Eurofins Scientific S.E. Main Business
Table 149. Eurofins Scientific S.E. Tumor NGS Detection Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 150. Eurofins Scientific S.E. Latest Developments
LIST OF FIGURES
Figure 1. Tumor NGS Detection Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tumor NGS Detection Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Tumor NGS Detection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Tumor NGS Detection Sales Market Share by Country/Region (2023)
Figure 8. Tumor NGS Detection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Tumor NGS Detection Market Size Market Share by Type in 2023
Figure 10. Tumor NGS Detection in Companion Diagnostics
Figure 11. Global Tumor NGS Detection Market: Companion Diagnostics (2019-2024) & ($ Millions)
Figure 12. Tumor NGS Detection in Early Cancer Screening
Figure 13. Global Tumor NGS Detection Market: Early Cancer Screening (2019-2024) & ($ Millions)
Figure 14. Tumor NGS Detection in Drug Discovery
Figure 15. Global Tumor NGS Detection Market: Drug Discovery (2019-2024) & ($ Millions)
Figure 16. Tumor NGS Detection in Other
Figure 17. Global Tumor NGS Detection Market: Other (2019-2024) & ($ Millions)
Figure 18. Global Tumor NGS Detection Market Size Market Share by Application in 2023
Figure 19. Global Tumor NGS Detection Revenue Market Share by Player in 2023
Figure 20. Global Tumor NGS Detection Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Tumor NGS Detection Market Size 2019-2024 ($ Millions)
Figure 22. APAC Tumor NGS Detection Market Size 2019-2024 ($ Millions)
Figure 23. Europe Tumor NGS Detection Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Tumor NGS Detection Market Size 2019-2024 ($ Millions)
Figure 25. Americas Tumor NGS Detection Value Market Share by Country in 2023
Figure 26. United States Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Tumor NGS Detection Market Size Market Share by Region in 2023
Figure 31. APAC Tumor NGS Detection Market Size Market Share by Type in 2023
Figure 32. APAC Tumor NGS Detection Market Size Market Share by Application in 2023
Figure 33. China Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Tumor NGS Detection Market Size Market Share by Country in 2023
Figure 40. Europe Tumor NGS Detection Market Size Market Share by Type (2019-2024)
Figure 41. Europe Tumor NGS Detection Market Size Market Share by Application (2019-2024)
Figure 42. Germany Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Tumor NGS Detection Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Tumor NGS Detection Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Tumor NGS Detection Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 56. APAC Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 57. Europe Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 59. United States Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 60. Canada Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 63. China Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 64. Japan Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 65. Korea Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 67. India Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 68. Australia Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 69. Germany Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 70. France Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 71. UK Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 72. Italy Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 73. Russia Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 74. Spain Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 77. Israel Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 80. Global Tumor NGS Detection Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Tumor NGS Detection Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Tumor NGS Detection Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tumor NGS Detection Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Tumor NGS Detection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Tumor NGS Detection Sales Market Share by Country/Region (2023)
Figure 8. Tumor NGS Detection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Tumor NGS Detection Market Size Market Share by Type in 2023
Figure 10. Tumor NGS Detection in Companion Diagnostics
Figure 11. Global Tumor NGS Detection Market: Companion Diagnostics (2019-2024) & ($ Millions)
Figure 12. Tumor NGS Detection in Early Cancer Screening
Figure 13. Global Tumor NGS Detection Market: Early Cancer Screening (2019-2024) & ($ Millions)
Figure 14. Tumor NGS Detection in Drug Discovery
Figure 15. Global Tumor NGS Detection Market: Drug Discovery (2019-2024) & ($ Millions)
Figure 16. Tumor NGS Detection in Other
Figure 17. Global Tumor NGS Detection Market: Other (2019-2024) & ($ Millions)
Figure 18. Global Tumor NGS Detection Market Size Market Share by Application in 2023
Figure 19. Global Tumor NGS Detection Revenue Market Share by Player in 2023
Figure 20. Global Tumor NGS Detection Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Tumor NGS Detection Market Size 2019-2024 ($ Millions)
Figure 22. APAC Tumor NGS Detection Market Size 2019-2024 ($ Millions)
Figure 23. Europe Tumor NGS Detection Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Tumor NGS Detection Market Size 2019-2024 ($ Millions)
Figure 25. Americas Tumor NGS Detection Value Market Share by Country in 2023
Figure 26. United States Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Tumor NGS Detection Market Size Market Share by Region in 2023
Figure 31. APAC Tumor NGS Detection Market Size Market Share by Type in 2023
Figure 32. APAC Tumor NGS Detection Market Size Market Share by Application in 2023
Figure 33. China Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Tumor NGS Detection Market Size Market Share by Country in 2023
Figure 40. Europe Tumor NGS Detection Market Size Market Share by Type (2019-2024)
Figure 41. Europe Tumor NGS Detection Market Size Market Share by Application (2019-2024)
Figure 42. Germany Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Tumor NGS Detection Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Tumor NGS Detection Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Tumor NGS Detection Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Tumor NGS Detection Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 56. APAC Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 57. Europe Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 59. United States Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 60. Canada Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 63. China Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 64. Japan Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 65. Korea Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 67. India Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 68. Australia Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 69. Germany Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 70. France Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 71. UK Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 72. Italy Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 73. Russia Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 74. Spain Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 77. Israel Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Tumor NGS Detection Market Size 2025-2030 ($ Millions)
Figure 80. Global Tumor NGS Detection Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Tumor NGS Detection Market Size Market Share Forecast by Application (2025-2030)
